John Maraganore, CEO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 15,076 shares at $64.56 ($962K) on 2016-07-19, disclosed to the SEC on 2016-07-21.
Open-market sale of $962k ALNY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.73 | 13,571 | $865K | 89.9% |
| 2 | $64.56 | 1,505 | $97K | 10.1% |
| Total | $63.81 avg | 15,076 | $962K | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |